Accelerating the Next Generation of Immune Medicine with Fully Automated High-Plex Cellular Proteomics

Wed20  Oct12:45pm(5 mins)
Room 3A
Mr Mourad Ferhat


IsoPlexis’ unique new high-plex automated immunoassay applications uniquely enable decentralization of multiplexed and fully automated functional proteomics for accelerated insights. This technology can identify 20-30 cytokines in bulk or at the single-cell level, with only 11 µL of sample per chip, analyzed on the fully automated Isospark and Isolight systems. IsoPlexis’ proteomics platform widens access to advanced insights provided by improved and re-engineered ELISA technology, with a small footprint and end-to-end automation. Recently, high-plex automated immunoassays were utilized in multiple high-impact studies, characterizing CAR-T cell therapies to treat patients with recurrent or refractory B cell malignancies, and in discovering key inflammatory mediators in severe COVID-19.
In this talk we will describe how high-plex automated immunoassays facilitate critical discoveries in immune medicine, accelerating the development of advanced therapeutics across different disciplines such as cancer immunology, cellular therapy, infectious disease and inflammation.
To view the video assoicated with this lecture click here

Hosted By


The European Laboratory Research & Innovation Group Our Vision : To provide outstanding, leading edge knowledge to the life sciences community on an open access basis
Event Logo Find us on Facebook Follow us on Twitter

Get the App

Get this event information on your mobile by
going to the appstore or google play and search for 'elrig'
Eventflo Home
copyright ELRIG,, Labhoo Ltd 2003-2022